Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-01-16
2007-01-16
Myers, Carla J. (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C435S091210, C435S091500, C435S091510
Reexamination Certificate
active
10296739
ABSTRACT:
The invention concerns a method for the diagnosis and/or the follow up of the evolution of cancer comprising the analysis of the RNA components of the telomerase enzyme present in the plasma or serum of the blood.
REFERENCES:
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4699877 (1987-10-01), Cline et al.
patent: 4874858 (1989-10-01), Magistro
patent: 4999290 (1991-03-01), Lee
patent: 5087617 (1992-02-01), Smith
patent: 5098890 (1992-03-01), Gewirtz et al.
patent: 5124246 (1992-06-01), Urdea et al.
patent: 5155018 (1992-10-01), Gillespie et al.
patent: 5217889 (1993-06-01), Roninson et al.
patent: 5274087 (1993-12-01), Barnett et al.
patent: 5300635 (1994-04-01), Macfarlane
patent: 5409818 (1995-04-01), Davey et al.
patent: 5470724 (1995-11-01), Ahern
patent: 6132965 (2000-10-01), Austin et al.
patent: 6166178 (2000-12-01), Cech et al.
patent: 6329179 (2001-12-01), Kopreski
patent: 6607898 (2003-08-01), Kopreski et al.
patent: 6610839 (2003-08-01), Morin et al.
patent: 6821726 (2004-11-01), Dahm et al.
patent: 3717212 (1988-12-01), None
patent: 0 841 396 (1998-05-01), None
patent: 0 926 245 (1999-06-01), None
patent: 0 990 701 (2000-04-01), None
patent: WO 90/09456 (1990-08-01), None
patent: WO 97/18322 (1997-05-01), None
patent: WO 97/35589 (1997-10-01), None
patent: WO 98/28442 (1998-07-01), None
patent: WO 99/40221 (1999-08-01), None
patent: WO 99/41406 (1999-08-01), None
Kopreski et al. Clinical Cancer Research (1999) 5: 1961-1965.
Gertler et al. Cancer. 2002. 95: 2103-2111, see p. 2104.
Feng et al. Science. 1995. 269: 1236-1241.
Kim et al. Science. 1994. 266: 2011-2015.
Yajima et al., “Establishment of quantitative reverse transcription-polymerase chain reaction assays for human telomerase-associated genes”, Clinica Chimica Acta, 290, 2000, pp. 117-127.
De Kok et al., “Real-Time Quantification of Human Telomerase Reverse Transcriptase mRNA in Tumors and Healthy Tissues”, Clinical Chemistry, 46:3, 2000, pp. 313-318.
Shay, “Telomerase in Human Development and Cancer”, Journal of Cellular Physiology, 173, 1997, pp. 266-270.
Kim et al., “Specific Association of Human Telomerase Activity with Immortal Cells and Cancer”, Science, vol. 266, Dec. 23, 1994, pp. 2011-2015.
Novakovic et al., “Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer”, Oncology Reports, vol. 11, 2004, pp. 245-252.
Miura et al., “Serum Human Telomerase Reverse Transcriptase Messenger RNA as a Novel Tumor Marker for Hepatocellular Carcinoma”, Clinical Cancer Research, vol. 11, May 1, 2005, pp. 3205-3209.
Dragon et al., “In Vitro Assembly of Human H/ACA Small Nucleolar RNPs Reveals Unique Features of U17 and Telomerase RNAs”, Molecular and Cellular Biology, vol. 20, No. 9, 2000, pp. 3037-3048.
Chen et al., “Telomerase RNA as a Detection Marker in the Serum of Breast Cancer Patients”, Clinical Cancer Research, vol. 6, Oct. 2000, pp. 3823-3826.
Yi et al., “Both Transcriptional and Posttranscriptional Mechanisms Regulate Human Telomerase Template RNA Levels”, Molecular and Cellular Biology, vol. 19, No. 6, Jun. 1999, pp. 3989-3997.
Kopreski et al., “Detection of Tumor Messenger RNA in the Serum of Patients with Malignant Melanoma”, Clinical Cancer Research, vol. 5, Aug. 1999, pp. 1961-1965.
Bachand et al., “Expression of hTERT and hTR incisreconstitutes an active human telomerase ribonucleoprotein”, RNA, vol. 6, 2000, pp. 778-784.
Harrington et al., “A Mammalian Telomerase-Associated Protein”, Science, vol. 275, Feb. 14, 1997, pp. 973-977.
Nugent et al., “The telomerase reverse transcriptase: components and regulation”, Genes & Development, vol. 12, 1998, pp. 1073-1085.
Oulton et al., “Telomeres, telomerase, and cancer: life on the edge of genomic stability”, Current Opinion in Oncology, vol. 12, 2000, pp. 74-79.
Anker, “Quantitative Aspects of Plasma/Serum DNA in Cancer Patients”, Annals New York Academy of Sciences, pp. 5-7.
Joost, C.B.M. et al., Assembly of Transcriptionally Active RNA Polymerase I Initiation Factor SL1 from Recombinant Subunits, Science, vol. 266, Dec. 23, 1994.
Alkema et al., “Characterization and Chromosamal Localization of the Human Prata-Oncogene BMI-1,”Human Mol Genet2:1597-1603 (1993).
Aoki et al., “Liposome-mediated in viva gene transfer on antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity,”Cancer Research55:3810-3816 (1995).
Barz et al., “Characterization of Cellular and Extracellular Plasma Membrane Vesicles from a Non-metastasing Lymphoma (Eb) and Its Metastasing Variant (Esb),”Biochin Biophys Acta814:77-84 (1985).
Bauer et al., “Identification of H-2Kb Binding and Immunogenic Peptides from Human Papillama Virus Tumour Antigens E6 and E7,”Scand J Immunol42:317-323 (1995).
Blackburn et al., “Electrochemiluminescence detection for development of immunoassays and DNA probe assays for clinical diagnostics,”Olin Chem37/9:1534-1539 (1991).
Bocchia et al., “Specific Binding of Leukemia Oncogene Fusion Peptides to HLA Class I Molecules,”Blood85:2680-2684 (1995).
Boom et al., “Rapid and Simple Method for Purification of Nucleic Acids,”J Clin Micro28:495-503 (1990).
Brossart et al., “Detection of residual tumor cells in patients with malignant melanoma responding to immunotherapy,”J Immunotherapy15:38-41 (1994).
Carr et al., “Circulating Membrane Vesicles in Leukemic Blood,”Cancer Research45:5944-5951 (1985).
Cheung et al., “Rapid and Sensitive Method for Detection of Hapatitis C Virus RNA by Using Silica Particles,”J Clin Micro32:2593-2597 (1994).
Chomczynski and Mackey, “Modification of the TRI reagent (TM) procedure for isolation of RNA from polysaccaride- and proteaglycan-rich sources,”Bio Techniques19:942-945 (1995).
Chomczynski and Mackey, “Substitution of chloroform by bromo-chloropropane in the single-step method of RNA isolation,”Analytical Biochemistry225:163-164 (1995).
Chomczynski et al., “Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction,”Analytical Biochemistry162:156-159 (1987).
Chomczynski, “A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples,”Biotech15:532-537 (1993).
Chu et al., “Thymidylate synthase binds to c-myc RNA in human colon cancer cells and in vitro,”Mol Cell Biol15:179-185 (1995).
Cohen, “Biochemical Therapy: Antisense Compounds,”In: Biologic Teraphy of Cancer(DeVita, Hellman, Rosenberg, eds) J.B. Lippincott, Ca., Philadelphia (1991) pp. 763-775.
Colomer et al., “erB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erb-2 oncogene amplification,”Br J Cancer70:819-825 (1994).
Coutlee et al., “Immunodetection of DNA with biotinylated RNA probes: A study of reactivity of a monoclonal antibody to DNA-RNA hybrids,”Analytical Biochemistry181:96-105 (1989).
Datta et al., “Sensitive Detection of Occult Breast Cancer by the Reverse-transcriptase Polymerase Chain Reaction,”Journal of Clinical Oncology12:475-482 (1994).
Davidova and Shapot, “Liporibonucleoprotein Complex as an Integral Part of Animal Cell Plasma Membranes,”FEBS Lett6:349-351 (1970).
DiCesare et al., “A high-sensitivity electrochemiluminescense-based detection system for automated PCR product quantitation,”BioTechniques15:152-157 (1993).
Doi et al., “Detection of beta-human chorionic ganadotropin mRNA as a marker for cutaneoud malignant melanoma,”Int J Cancer65:454-45- (1996).
Dosaka et al., “A complex pattern of translational initiation and phosphorylation in L-Myc Proteins,”Oncogene6:371-378 (1991).
Feng et al., “The RNA comp
Anker Philippe
Chen Xu Qi
Stroun Maurice
Myers Carla J.
Young & Thompson
LandOfFree
Cancer diagnosis method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cancer diagnosis method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer diagnosis method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3781474